Pathogenesis of and immunity to avian influenza A H5 viruses

Biomedicine and Pharmacotherapy

Volumn 54, Issue 4, 2000, Pages 178-187

  Katz, J M ^a   Lu, X ^c   Frace, A M ^a   Morken, T ^b   Zaki, S R ^b   Tumpey, T M ^a  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c Cetr for Disease Control/Prevention ^*

Author keywords

Immunity; Influenza H5N1; Pathogenesis

Indexed keywords

VIRUS ANTIGEN;

ARTICLE; CONTROLLED STUDY; IMMUNITY; IMMUNIZATION; IMMUNOHISTOCHEMISTRY; INFLUENZA VIRUS A; MOUSE; NONHUMAN; PATHOGENICITY; PHENOTYPE; PRIORITY JOURNAL; VIRUS ISOLATION; VIRUS REPLICATION;

EID: 0034193772     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0753-3322(00)89024-1     Document Type: Article

References (30)

1. Bender C, Hall H, Huang J, Klimov A, Cox N, Hay A, et al. Characterization of the surface proteins of influenza A (H5N1) viruses isolated from humans in 1997-1998. Virology 1999 ; 254 : 115-23.
2. Bridges CB, Katz JM, Seto WH, Chan PK, Tsang D, Ho W, et al. Risk of influenza A (H5N1) infection among health care workers exposed to patients with influenza A (H5N1), Hong Kong. J Infect Dis 2000 ; 181 : 344-8.
3. Claas ECJ, Osterhaus ADME, Van Beek R, de Jong JC, Rimmelzwaan GF, Senne DA, et al. Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus. Lancet 1998 ; 351 : 472-7.
4. Centers for Disease Control and Prevention. Isolation of avian influenza A (H5N1) viruses from humans-Hong Kong, May-December. Mor Mortal Wkly Rep 1997 ; 46 : 1204-7.
5. Centers for Disease Control and Prevention. Update: Isolation of avian influenza A (H5N1) viruses from humans-Hong Kong, 1997-1998. Mor Mortal Wkly Rep 1998 ; 46 : 1245-7.
6. De Jong JC, Claas EJC, Osterhaus ADME, Webster RG, Lim WL. A pandemic warning? Nature 1997 ; 389 : 554.
7. Dybing JK, Schultz-Cherry S, Swayne DE, Suarez DL, Perdue ML. Distinct pathogenesis of Hong Kong-origin H5N1 viruses in mice compared to that of other highly pathogenic H5 avian influenza viruses. J Virol 2000 ; 74 : 1443-50.
8. Gao P, Watanabe S, Ito T, Goto H, Wells K, McGregor M, et al. Biological heterogeneity, including systemic replication in mice, of H5N1 influenza A virus isolates from humans in Hong Kong. J Virol 1999 ; 73 : 3184-9.
9. Gubareva LV, McCullers JA, Bethell RC, Webster RG. Characterization of influenza A/Hong Kong/156/97 (H5N1) virus in a mouse model and protective effect of Zanamavir on H5N1 infection in mice. J Infect Dis 1998 ; 178 : 1592-6.
10. Hoie CE, Hinshaw VS. Induction and activity of class II-restricted, Lyt-2+ cytolytic T lymphocytes specific for the influenza H5 hemagglutinin. J Immunol 1989 ; 142 : 2482-8.
11. Hoie CE, Dybdahl-Sissoko N, Philpott M, Hinshaw VS. Overlapping cytotoxic T-lymphocyte and B-cell antigenic sites on the influenza virus H5 hemagglutinin. J Virol 1990 ; 64 : 6246-51.
12. Katz JM, Lim W, Bridges CB, Rowe T, Hu-Primmer J, Lu X, et al. Antibody response in individuals infected with avian influenza A (H5N1) viruses and detection of anti-H5 antibody among household and social contacts. J Infect Dis 1999 ; 180 : 1763-70.
13. Katz JM, Lu X, Young SA, Galphin JC. Adjuvant activity of the heat-labile enterotoxin from enterotoxigenic Escherichia coli for oral administration of inactivated influenza virus vaccine. J Infect Dis 1997 ; 175 : 352-63.
14. Kawaoka Y, Krauss S, Webster RG. Avian-to-human transmission of the PB1 gene of influenza A virus in the 1957 and 1968 pandemics. J Virol 1989 ; 63 : 4603-8.
15. Kendal AP, Skehel JJ, Pereira MS. In: Concepts and procedures for laboratory-based influenza surveillance. Atlanta: Centers for Disease Control; 1982. p. B17-35.
16. Lu, X, Tumpey TM, Morken T, Zaki SR, Cox NJ, Katz J. A mouse model for the evaluation of pathogenesis and immunity to influenza A (H5N1) viruses isolated from humans. J Virol 1999 ; 73 : 5903-11.
17. Mounts AW, Kwong H, Izurieta HS, Ho YY, Au TK, Lee M, et al. Case-control study of risk factors for avian influenza A (H5N1) disease, Hong Kong, 1997. J Infect Dis 1999 ; 180 : 505-8.
18. Powers DC, Smith GE, Anderson EL, Kennedy DJ, Hackett CS, Wikinson BE, et al. Influenza A virus vaccines containing purified recombinant H3 hemagglutinin are well tolerated and induce protective immune responses in healthy adults. J Infect Dis 1995 ; 171 : 1595-9.
19. Reed LJ, Muench H. A simple method of estimating fifty percent endpoints. Am J Hyg 1938 ; 27 : 493-7.
20. Richmond JY, McKinney RW. In: Richmond JY, McKinney RW, eds. Biosafety in Microbiological and Biomedical Laboratories. U.S. Department of Health and Human Services, Centers for Disease Control: Atlanta; 1999. p. 17-51.
21. Scholtissek C, Rhode W, Von Hoyingen V, Rott R. On the origin of the human influenza virus subtypes H2N2 and H3N2. Virology 1978 ; 87 : 13-20.
22. Senne DA, Panigrapy B, Kawaoka Y, Pearson JE, Suss J, Lipkind M, et al. Survey of the hemagglutinin (HA) cleavage site sequence of H5 and H7 avian influenza viruses: Amino acid sequence at the HA cleavage site as a marker of pathogenicity potential. Avian Dis 1996 ; 40 : 425-37.
23. Shortridge KF, Zhou NN, Guan Y, Gao P, Ito T, Kawaoka Y, et al. Characterization of avian H5N1 influenza viruses from poultry in Hong Kong. Virology 1998 ; 252 : 331-42.
24. Suarez DL, Perdue ML, Cox NJ, Rowe T, Bender C, Huang J, et al. Comparisons of highly virulent H5N1 influenza A viruses isolated from humans and chickens from Hong Kong. J Virol 1998 ;72 : 6678-88.
25. Subbarao K, Klimov A, Katz J, Regnery H, Lim W, Hall H, et al. Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. Science 1998 ; 279 : 393-6.
26. Tumpey TM, Lu X, Morken T, Zaki SR, Katz JM. Depletion of lymphocytes and diminished cytokine production in mice infected with a highly virulent influenza A (H5N1) virus isolated from humans. J Virol 2000 ; in press.
27. Van Campen H, Easterday BC, Hinshaw VS. Destruction of lymphocytes by a virulent avian influenza A virus. J Gen Virol 1989 ; 70 : 467-72.
28. Wood JM, Major D, Daly J, Newman RW, Dunleavy U, Nicolson C, et al. Vaccines against H5N1 influenza. Vaccine 2000 ;18 : 579-80.
29. Yuen KY, Chan PK, Peiris M, Tsang DNC, Que XL, Shortridge KF, Members Of The H5N1 Study Group, et al. Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus. Lancet 1998 ; 351 : 467-71.
30. Zaki SR, Greer PW, Coffield LM, Goldsmith CS, Nolte KB, Foucar K, et al. Hantavirus pulmonary syndrome: Pathogenesis of an emerging infectious disease. Am J Pathol 1995 ; 146 : 552-79.